Policy

WHO 3rd Global Patient Safety Challenge launched at the Global Ministerial Summit on Patient Safety in Bonn

Policy
Dr. Matthias Wienold , our board member and Treasurer, attended the high profile 2nd Global Ministerial Summit on Patient Safety in Bonn in March 2017 and reports back on the launch of the 3rd Global Patients Safety Challenge: Medication Without Harm. IAPO and its members will support this campaign over the coming years.

Resumen de Políticas #3 – Acceso de calidad a la atención sanitaria

Policy
El resumen de políticas de este mes está centrado en el acceso que es el segundo “tema clave” del plan de compromiso y empoderamiento 2017 ( 2017 engagement and empowerment plan ). El acceso y el apoyo también figuran entre los cinco principios de la Declaración de la IAPO sobre la asistencia...

Resumen de Políticas #2 – Información del paciente y alfabetización sanitaria

Policy
El resumen de políticas de este mes está centrado en la información del paciente. La información del paciente es uno de los pilares sobre los cuales se fundamenta el concepto de asistencia sanitaria centrada en el paciente. Cuando la información es exacta, completa y fácil de entender los pacientes pueden fortalecer su conocimiento sobre los procesos sanitarios y sus mecanismos.

Sovereignty preventing global drug regulation harmonization-International Conference of Drug Regulatory Authorities

Policy
The International Conference of Drug Regulatory Authorities (ICDRA) is an annual event hosted for the benefit of the WHO Member States and their national medicines regulatory authorities (NMRAs); many non-State actors attend a pre-ICDRA conference to share their views with NMRAs. The 17th pre-ICDRA...

UK Supreme Court closes the gap between ‘legal consent’, ‘informed consent’ and the ‘best interest’ of the patients!

Policy
UK Supreme Court (UKSC) judgment in Montgomery v Lanarkshire Health Board has closed the gap between ‘legal consent’, ‘informed consent’ and the ‘best interest’ of the patients. The full judgment, the point of law decided and the rationale for the decision (ratio decidendi) of this important case...

Can medically educated patients solve the global shortage of quality health professionals for UHCs by 2030?

Policy
WHO World Health Assembly (May 2016), WHO Regional Committee Meetings (Sep-Oct 2016) and the UN General Assembly Debate (Sep 2016) had great discussions on SDG 2030, UHC and health workforce strengthening. Kawaldip Sehmi, our CEO, has assembled critical thinking on this matter of some of the '...

Patient involvement in medical education: 'educating-in' patient centredness

Policy
Dr. Matthias Wienold (IAPO Treasurer and Board Member) and Stijntje Dijk (Liaison Officer International Federation of Medical Students Associations (IFMSA) ) Stijntje, whom you all met at our Global Patients Congress 2016, and I held a joint workshop at the Association for Medical Education in...

Will the UN General Assembly be able to address the health needs of migrant and refugee patients?

Policy
Board member Hussain Jafri reporting from the multi-stakeholder hearing of the UN General Assembly High-Level Summit on migrants and refugees 18-22 July 2016, United Nations, New York The most vulnerable patients in the world From the jungles of Central America, deserts of North Africa to the...

La corrupción puede ser la diferencia entre vida y muerte

Policy
La corrupción en el sector de la salud puede hacer la diferencia entre la vida y la muerte, y a menudo son las personas más pobres del mundo las que son afectadas más.

Improving patient experience in clinical trials

Policy
A group of 18 leading biopharmaceutical companies have come together share ideas, simplify and speed up the research and development of new drugs, and improve patient experience around the globe.

Pages

Subscribe to RSS - Policy